Intelligence for decisions, partnerships and market expansion.
Economic reporting from around the world, filtered to the sectors and policy areas our members build in — part of the same intelligence stream behind the Global Economic Outlook and NiDCC's market reports.
Regeneron Pharmaceuticals announced the presentation of new clinical research at the European Society for Medical Oncology (ESMO) Congress 2026, highlighting advances in treating v...
UnitedHealth Group Incorporated (UNH) is scheduled to release its Q3'26 earnings on October 13, before the market opens, with an estimated revenue of $111.31 billion and an EPS of...
Adam Crystal, President of Research & Development at Tango Therapeutics (NASDAQ:TNGX), sold 27,000 shares for $660,796 on October 1, 2026, under a pre-arranged trading plan, after...
Cantor Fitzgerald has reiterated a Neutral rating and a USD 400.00 price target for Amgen stock. This comes as Amgen announced positive Phase 3 trial results for dazodalibep and re...
BD (Becton, Dickinson and Company) has appointed Ferass Abuzaina as the worldwide president of its Surgery business unit, effective immediately. Abuzaina will be responsible for th...
Vaxcyte's VAX-31 pneumococcal vaccine has shown promising results in Phase 3 trials, matching or exceeding the performance of Pfizer's Prevnar 20 and Merck's Capvaxive. This new ch...
BD (Becton, Dickinson and Company) has announced a landmark partnership with the U.S. Government to significantly expand domestic manufacturing of essential medical consumables. Th...
Kenvue has presented new scientific evidence for its Neutrogena, Aveeno, and Regaine brands, while its stock currently sits 13.61 percent below its 52-week high. The company report...
SOPHiA GENETICS SA (NASDAQ:SOPH) has received a consensus "Hold" rating from analysts, with an average 12-month price target of $10.00. While the company's quarterly revenue exceed...
Verrica Pharmaceuticals (VRCA) closed at $4.31 on October 5, 2026, and is set to present new YCANTH and VP-315 clinical data at upcoming dermatology conferences, starting October 8...